Eknoyan Garabed, Lameire Norbert, Barsoum Rashad, Eckardt Kai-Uwe, Levin Adeera, Levin Nathan, Locatelli Francesco, MacLeod Alison, Vanholder Raymond, Walker Rowan, Wang Haiyan
Baylor College of Medicine, Houston, Texas 77030, USA.
Kidney Int. 2004 Oct;66(4):1310-4. doi: 10.1111/j.1523-1755.2004.00894.x.
Chronic kidney disease (CKD) is a worldwide public health problem. There is an increasing incidence and prevalence of patients with kidney failure requiring replacement therapy, with poor outcomes and high cost. There is an even higher prevalence of patients in earlier stages of CKD, with adverse outcomes such as kidney failure, cardiovascular disease, and premature death. Patients at earlier stages of CKD can be detected through laboratory testing and their treatment is effective in slowing the progression to kidney failure and reducing cardiovascular events. The science and evidence-based care of these patients are universal and independent of their geographic location. There is a clear need to develop a uniform and global public health approach to the worldwide epidemic of CKD. It is to this end that a new initiative "Kidney Disease: Improving Global Outcomes" has been established. Its stated mission is "Improve the care and outcomes of kidney disease patients worldwide through promoting coordination, collaboration and integration of initiatives to develop and implement clinical practice guidelines."
慢性肾脏病(CKD)是一个全球性的公共卫生问题。需要替代治疗的肾衰竭患者的发病率和患病率不断上升,治疗效果不佳且成本高昂。CKD早期阶段的患者患病率更高,会出现诸如肾衰竭、心血管疾病和过早死亡等不良后果。CKD早期阶段的患者可通过实验室检测发现,对他们的治疗在减缓肾衰竭进展和减少心血管事件方面是有效的。这些患者的科学和循证护理是普遍适用的,且与地理位置无关。显然有必要制定一种统一的全球公共卫生方法来应对CKD在全球范围内的流行。为此,一项新的倡议“改善全球肾脏病预后(KDIGO)”已经启动。其既定使命是“通过促进各项举措的协调、合作与整合,以制定和实施临床实践指南,改善全球肾脏病患者的护理和预后”。